Medication Simplification Strategies in Older Adults: A Comprehensive Clinical Review

Abstract

Polypharmacy in older adults poses significant risks, including adverse drug events, drug-drug interactions, and medication non-adherence. Medication simplification strategies offer a targeted approach to minimize these risks by reducing regimen complexity without compromising therapeutic efficacy. This review synthesizes current scientific evidence, explores mechanisms underlying polypharmacy-related complications, and discusses practical strategies for medication simplification in geriatric care. Emphasis is placed on clinical implementation, patient-centered outcomes, and guideline-based recommendations to optimize pharmacotherapy in older adults.

Introduction

Managing pharmacotherapy in older adults is increasingly complex due to multimorbidity, age-related physiological changes, and the high prevalence of polypharmacy. Medication regimen complexity is a well-recognized contributor to medication errors, hospitalizations, and diminished quality of life. Simplification, distinct from deprescribing, involves streamlining regimens to facilitate adherence and safety. This article reviews epidemiology, pathophysiology, risk factors, clinical features, diagnostic considerations, and contemporary management strategies focused on medication simplification, supporting clinicians in delivering evidence-based care to geriatric populations.

Epidemiology / Disease Burden

Polypharmacy, often defined as the concurrent use of five or more medications, affects over 40% of adults aged 65 years and older in developed countries. The prevalence rises to nearly 60% in institutionalized populations. Medication regimen complexity, measured by tools like the Medication Regimen Complexity Index (MRCI), correlates strongly with adverse outcomes such as falls, cognitive impairment, and increased healthcare utilization. The burden of medication-related harm in older adults is substantial, with an estimated 10% of hospital admissions in this group attributed to adverse drug events, many of which are preventable through regimen simplification.

Pathophysiology

The pathophysiology underlying polypharmacy-related complications is multifaceted. Age-associated pharmacokinetic and pharmacodynamic changes such as reduced renal and hepatic clearance, altered drug distribution, and increased sensitivity to central nervous system agents heighten susceptibility to adverse drug reactions. Complex regimens exacerbate the risk of cumulative toxicity, drug-drug interactions, and therapeutic duplication. Cognitive decline, sensory impairment, and decreased manual dexterity further impede safe medication use, compounding regimen complexity and increasing the risk of non-adherence and medication errors.

Risk Factors

Key risk factors for medication regimen complexity in older adults include multimorbidity, polypharmacy, multiple prescribers, transitions of care (e.g., hospital discharge), and inadequate medication reconciliation. Social determinants such as low health literacy, limited caregiver support, and socioeconomic barriers can further complicate medication management. Certain medication classes, including psychotropics, anticholinergics, and cardiovascular agents, are frequently implicated in complex regimens and adverse outcomes.

Clinical Features

Clinically, complex medication regimens may manifest as poor adherence, increased pill burden, confusion regarding dosing schedules, and frequent medication errors. Older adults may present with nonspecific symptoms such as dizziness, falls, delirium, or unexplained functional decline. These features often prompt medication review and highlight the need for simplification strategies to improve therapeutic outcomes and patient safety.

Diagnosis

Assessment of medication regimen complexity involves a comprehensive medication review, utilizing tools like the MRCI and the Beers Criteria to identify potentially inappropriate medications. Detailed evaluation of pharmacotherapy should consider indications, duplications, dosing schedules, formulation appropriateness, and patient-specific factors such as renal or hepatic function. Clinical pharmacists and multidisciplinary teams play a crucial role in identifying targets for simplification and ensuring medication reconciliation at every care transition.

Treatment & Management

Medication simplification encompasses several strategies: consolidating dosing times, switching to fixed-dose combination products, selecting long-acting formulations, and eliminating unnecessary medications. Clinical implementation requires shared decision-making, explicit communication with patients and caregivers, and regular regimen reviews. Simplification must balance the need for therapeutic efficacy with the risks of under-treatment, particularly in conditions where polypharmacy is guideline-driven. Incorporating technology, such as blister packaging and electronic reminders, can further support adherence and safety in older adults.

Recent Advances / Emerging Therapies

Recent advances include the development of digital medication management platforms and artificial intelligence-driven medication review tools, which provide real-time recommendations for simplification. Ongoing research explores the impact of pharmacist-led simplification interventions on clinical outcomes, such as reduced hospitalization rates and improved quality of life. Emerging evidence highlights the role of deprescribing in conjunction with simplification, particularly for high-risk medications and patients with limited life expectancy.

Guideline Recommendations

Professional guidelines, including those from the American Geriatrics Society and the National Institute for Health and Care Excellence (NICE), endorse regular medication review and simplification as standard practice in geriatric care. Recommendations emphasize individualized assessment, prioritization of patient goals, and integration of pharmacological and non-pharmacological therapies. Interprofessional collaboration and education are identified as critical components for successful implementation of simplification strategies.

Conclusion

Medication simplification is a vital component of comprehensive geriatric care, aiming to reduce medication-related harm while maintaining therapeutic benefit. Evidence-based strategies, supported by clinical guidelines and emerging technologies, enable clinicians to optimize medication regimens for older adults. Routine medication review, multidisciplinary collaboration, and patient-centered care remain essential to successful simplification and improved health outcomes in the aging population.